Stay updated on Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial
Sign up to get notified when there's something new on the Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial page.

Latest updates to the Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial page
- CheckyesterdayChange DetectedA new revision entry v3.7.0 was added to the Record History, and the previous v3.6.6 entry was removed.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check22 days agoChange DetectedThe history now includes a new Revision: v3.6.6 entry, replacing the previous Revision: v3.6.5. This reflects a minor metadata update to the page’s version history on ClinicalTrials.gov.SummaryDifference0.1%

- Check44 days agoChange DetectedThe history shows a new site revision (v3.6.5) was added and the previous revision (v3.6.4) was removed, reflecting a minor system update.SummaryDifference0.1%

- Check58 days agoChange DetectedA new version entry, Revision: v3.6.4, appears in the history, replacing the prior Revision: v3.6.3. This reflects a minor update to the record's versioning on the page.SummaryDifference0.1%

- Check79 days agoChange DetectedA new release entry, Revision: v3.6.3, has been added to the study record's version history, following the previous Revision: v3.6.2.SummaryDifference0.1%

- Check86 days agoChange DetectedThe study history now includes a new revision entry v3.6.2 and removes the older v3.6.0 from the visible history. This updates the version record shown on the page.SummaryDifference0.1%

Stay in the know with updates to Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial page.